Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

58364 1487845784HCLSReviewSingaporeFeb2017.pdf
Energy Boardroom

Vimizim, an Ultra-Orphan Drug and a Success Story for BioMarin

02.06.2014 / Thomson Reuters Blog

Ulrike Jahnke, Editor at Thomson Reuters, discusses how BioMarin’s Vimizim, a drug for the ultra-rare lysosomal storage disorder Morquio A syndrome, brings hope to patients with such a rare, orphan condition and is also paying off financially for BioMarin thanks the price it can ask for an ultra-orphan drug. BioMarin Pharmaceutical recently launched Vimizim (elosulfase […]

Cover_HCLS_Singapore LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: